Oxford Global Conferences work with leading publications and trade associations on reciprocal marketing arrangements.

If you are interested in promoting your magazine/association to the leading players in technological and scientific trends & advances in Single Cell Analysis, please contact a.saez@oxfordglobal.co.uk

The Journal of Clinical and Translational Research (JCTR) is an open access, peer-reviewed, multidisciplinary scientific journal that publishes studies with at least an ex vivo, in vivo, or clinical component. The published research is centered on any clearly defined clinical problem, which may comprise a disease or the basis of disease, a form of therapy or intervention, and clinical diagnostics or prognostics. Articles (original research, reviews, technical reports, medical hypotheses, commissioned articles, special issue articles, and editorials) are published continuously online and bimonthly in print. Studies performed in cells only will generally not be accepted unless they contain critical data that are in line with the scope of the journal. Some examples of such studies include molecular pathways that lie at the basis of a disease, novel biotechnological approaches for e.g., the production of drugs, or new techniques that improve clinical diagnostics and prognostics. Articles that combine preclinical and clinical data are given priority. Contributions from academic institutions and industry are welcome.

The Journal of Clinical and Translational Research is currently working towards being indexed (Science Citation Index Expanded, Medline (PubMed), BIOSIS, Scopus).

Methods and Protocols(ISSN 2409-9279) is an open access journal devoted to the publication of new procedural approaches and cutting-edge methodological developments. With a broad interdisciplinary focus, Methods and Protocols was established with the objective of facilitating cross-fertilization and cross-talk in the scientific arena. Methods and protocols in Life Sciences, Chemistry, Biomedical Sciences, Engineering, and their intersections (Biotechnology, Nanotechnology, etc.) will constitute the core of the journal, and other fundamental disciplines such as Physics or Geology will be soon incorporated.

BlueSEQ Partners is a specialized global consulting firm focused on the Life Sciences, Digital Biology, and Genomics markets. Their unique blend of Business Management, Technology Understanding, and Strategy and Execution capabilities is what separates them from other consulting firms.

The BlueSEQ Partners group offers customized consulting teams to help their clients gain access to relevant industry C-level expertise, which many of their consultants have achieved over many years’ worth of successful management and scientific operations.

Bio-equip is a professional website which provides the information of equipment, consumables and chemical reagents in life science. The website which takes full advantage of the most up-to-date computer technologies and networks offers the most all-round and considerate service in the information of biology equipment.

Pharmalicensingis the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide.
Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world.
Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.

Pharmaceutical-Tech : In the realm of Pharmacy, where innovation is rapid, Pharmaceutical-Tech stands adept at conceptualizing unique ideas relevant to the B2B space. Pharmaceutical-Tech is essentially a B2B online business, technology media platform and global magazine that have under its wraps the largest global database of Pharmacy buyers and suppliers.

PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.

Technology Networksscientific communities offer today’s scientist a single resource that contains unique, engaging, and entertaining content from their field of research.